Glutamine

Glutamine

SCHEMBL2300574

NC(=O)CC[C@H](N)C(=O)O.Nc1ncnc2nc[nH]c12.O=C(O)c1cccnc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 2/20 0.41
▸ PI4K2B Q8TCG2 2/20 0.41
▸ PI4K2A Q9BTU6 2/20 0.41
▸ PI4KB Q9UBF8 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ XDH P47989 1/20 0.41
▸ LRRK2 Q5S007 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ APP P05067 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HCAR3 P49019 1/20 0.39
▸ HCAR2 Q8TDS4 1/20 0.39
▸ TOP2A P11388 2/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenine SCHEMBL1271542 0.86 PI4KA (0.55) PI4KAPI4K2BPI4K2API4KBLMNA
Glutamine SCHEMBL27878718 0.85 PI4KA (0.56) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL15700 0.80 PI4KA (0.55) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL2564210 0.80 PI4KA (0.55) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL22748487 0.80 PI4KA (0.55) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL8414755 0.79 PI4KA (0.51) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL23531102 0.79 PI4KA (0.54) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL11807683 0.79 PI4KA (0.54) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL7712108 0.79 PI4KA (0.54) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL1324561 0.79 PI4KA (0.54) PI4KAPI4K2BPI4K2API4KBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011101796-A1 A PHARMACEUTICAL COMPOSITION OF KILLED CELLS WITH SUBSTANTIALLY RETAINED IMMUNOGENICITY CADILA PHARMACEUTICALS LIMITED (IN) 2011-08-25 — — WO disclosed
Send feedback